Gemcitabine Gemolife Nv 200

Get a Price/Quote

MOQ : 10 Packs

Gemcitabine Gemolife Nv 200 Specification

Indication
Used for the treatment of various cancers including non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer

Dosage Form
Injection

Salt Composition
Gemcitabine 200 mg

Feature
Preservative-free, single use vial

Ingredients
Gemcitabine hydrochloride as active; excipients as per manufacturing guidelines

Application
Intravenous administration in clinical/medical settings

Physical Color/Texture
Not specified (typically clear liquid for injection)

Storage Instructions
Store below 25C, protect from light

Shelf Life
As mentioned on packaging or labeling (commonly 24 months from manufacturing)

Packaging Type
Single-dose vial

Generic Name
Gemcitabine

Reconstitution
Requires dilution before intravenous administration

Compatibility
Compatible with standard infusion solutions (consult pack insert)

Concentration
200 mg per vial

Clinical Use
Chemotherapy for various solid tumors

Route of Administration
Intravenous (IV) infusion

Brand Name
Gemolife NV-200

ATC Code
L01BC05 (general code for gemcitabine)

Prescription Status
Prescription only medication

Country Availability
Approved/available in Canada, Europe, UK, USA, Australia

Therapeutic Class
Antineoplastic (anticancer) agent

Gemcitabine Gemolife Nv 200 About

Gemcitabine Gemolife NV-200 is a prodigious solution in oncology, delivering a radiant approach for patients with various solid tumors. This astonishing, prescription-only anticancer agent-formulated as Gemcitabine hydrochloride 200 mg per vial-is compatible with popular infusion systems and recommended for use in Canada, Europe, the UK, USA, and Australia. Advance Purchase opportunities are available for hospitals and clinics, making Gemolife NV-200 a special choice among healthcare professionals. Offered in preservative-free, single-use vials, it promises quality consistent with industry standards. Store below 25C to maintain efficacy.

Gemcitabine Gemolife NV-200: Trusted Chemotherapy for Broad Oncology Use

Used by oncology specialists and clinicians, Gemcitabine Gemolife NV-200 targets non-small cell lung, pancreatic, bladder, and breast cancers. Its specific use lies in potent antineoplastic therapy, while its general use extends to various solid tumor indications. Commercially, it is in demand among hospitals, clinics, and cancer treatment centers. This injection is vital for comprehensive cancer care and trusted for its efficacy and safety profile worldwide.

Certifications, Freight, and Export Capability for Gemcitabine Gemolife NV-200

Gemolife NV-200 holds regulatory approvals in key international markets. All shipped goods depart from India, with FOB port options tailored to client requirements. Export market support includes thorough documentation and sample policy provisions for institutional clients. Freight solutions are customizable, ensuring reliable delivery and optimal sample handling for evaluation purposes prior to large-scale purchases. Certifications and protocols guarantee compliance with global quality standards.

FAQ's of Gemcitabine Gemolife Nv 200:

Q: How should Gemcitabine Gemolife NV-200 be administered?

A: Gemcitabine Gemolife NV-200 is administered through intravenous (IV) infusion after proper dilution. Healthcare professionals should follow reconstitution and compatibility instructions as detailed in the packaging insert.

Q: What cancers can be treated with Gemcitabine Gemolife NV-200?

A: This medication is indicated for the treatment of various solid tumors such as non-small cell lung cancer, pancreatic cancer, bladder cancer, and breast cancer.

Q: When should healthcare providers use Gemolife NV-200 over other chemotherapy agents?

A: Gemolife NV-200 is selected based on clinical guidelines, cancer type, stage, and patient-specific factors. It is commonly chosen where gemcitabine-based therapy is indicated and approved in the patient's country.

Q: Where is Gemcitabine Gemolife NV-200 available for purchase?

A: This product is approved and available in Canada, Europe, the UK, USA, and Australia. It is typically supplied through authorized distributors, manufacturers, or direct procurement channels in compliance with regulatory requirements.

Q: What is the process to purchase Gemolife NV-200 for institutional use?

A: Institutions can request samples, obtain quotations, and coordinate freight and shipment from India with FOB port options. Advance purchase agreements and documentation support are available to streamline export and delivery.

Q: How does Gemolife NV-200 benefit healthcare providers and patients?

A: Gemolife NV-200 offers reliable dosage, ease of preparation, compatibility with standard infusion systems, and widespread approval. Its efficacy contributes to comprehensive oncology care, benefiting both clinicians and patients.

Tell us about your requirement